AffaMed Therapeutics
PrivateLast Round
Series B
Mar 30, 2021
Total Funding Raised
$250M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AffaMed Therapeutics is a biopharmaceutical company that develops and commercializes transformative pharmaceutical products for ophthalmic, neurological, and psychiatric disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AffaMed Therapeutics Comparables
Compare AffaMed Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arctic Vision | 88% | |
| Allgenesis Biotherapeutics Inc. | 80% | |
| Ocumension Therapeutics | 78% | |
AffaMed Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 30, 2021 | ||||
| Series A | Feb 1, 2019 |
AffaMed Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lake Bleu Capital | Series B |
| CBC Group | Series B, Series A |
| Superstring Capital Management | Series B |
| Fountainhead Partners | Series B |
| Partners Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 8, representing 25% of headcount.
- Jun 21, 2026
Monthly visitors increased 30% MoM.
AffaMed Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AffaMed Therapeutics's valuation, stock price, and market status.